Astellas will close a stem cell…
Astellas will close a stem cell therapy site. GSK is [...]
Astellas will close a stem cell therapy site. GSK is [...]
Nationwide, hospitals and other providers are leaving private Medicare Advantage [...]
The recall affects only a small number of pills, sold [...]
Viatris and Teva Pharmaceutical Industries recently launched separate recalls related [...]
The review said a certain class of drugs had little [...]
Millions of Americans are experimenting with the drugs. Science can’t [...]
The FDA’s Pharmacy Compounding Advisory Committee will convene this summer [...]
Travere is eyeing a collective $3 billion U.S. opportunity for [...]
Even as Eli Lilly gets underway with its next major [...]
Protagonist Therapeutics-partnered Icotyde has the potential to become one of [...]